Cargando…
Medical cannabis patterns of use and substitution for opioids & other pharmaceutical drugs, alcohol, tobacco, and illicit substances; results from a cross-sectional survey of authorized patients
BACKGROUND: A 239-question cross-sectional survey was sent out via email in January 2017 to gather comprehensive information on cannabis use from Canadian medical cannabis patients registered with a federally authorized licensed cannabis producer, resulting in 2032 complete surveys. METHODS: The sur...
Autores principales: | Lucas, Philippe, Baron, Eric P., Jikomes, Nick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350348/ https://www.ncbi.nlm.nih.gov/pubmed/30691503 http://dx.doi.org/10.1186/s12954-019-0278-6 |
Ejemplares similares
-
Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach
por: Lachenmeier, Dirk W., et al.
Publicado: (2015) -
Author Correction: The Cannabinoid Content of Legal Cannabis in Washington State Varies Systematically Across Testing Facilities and Popular Consumer Products
por: Jikomes, Nick, et al.
Publicado: (2020) -
Cannabis as a substitute for alcohol and other drugs
por: Reiman, Amanda
Publicado: (2009) -
Non-medical use of pharmaceutical opioids with and without other illicit substance use: Trends from two repeated nationally representative Australian surveys
por: Leung, Janni, et al.
Publicado: (2022) -
Acceptance of pharmaceutical cannabis substitution by cannabis using patients with schizophrenia
por: van Amsterdam, Jan, et al.
Publicado: (2018)